The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis (Q31132502)

29 June 2017

1 reference

title

The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis (English)

1 reference

29 June 2017

0 references

1 reference

Pnina Fishman

1 reference

29 June 2017

Sara Bar-Yehuda

1 reference

29 June 2017

Michael H Silverman

1 reference

29 June 2017

William D Kerns

1 reference

29 June 2017

Avivit Ochaion

1 reference

29 June 2017

Shira Cohen

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Investigational Drugs

29 June 2017

published in

1 reference

29 June 2017

1 reference

29 June 2017

1 reference

29 June 2017

page(s)

1601-1613

1 reference

New concepts in the treatment of rheumatoid arthritis

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

How is it best to treat early rheumatoid arthritis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Adenosine receptors: new opportunities for future drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

IB-MECA and cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

The A3 adenosine receptor as a new target for cancer therapy and chemoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

A3 adenosine receptor as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Pharmacology and therapeutic applications of A3 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

New insights into the regulation of inflammation by adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Adenosine A2A agonists in development for the treatment of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Multiple signaling states of G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Akt: versatile mediator of cell survival and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

NF-kappaB and rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Inhibition of transcription factors by anti-inflammatory and anti-rheumatic drugs: can variability in response be overcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Vasoactive intestinal peptide ameliorates synovial cell functions of collagen-induced arthritis rats by down-regulating NF-kappaB activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Apoptosis as a therapeutic tool in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3β, and induction of the mitochondrial-dependent intrinsic caspase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Mechanisms of immune injury in rheumatoid arthritis: evidence for the involvement of T cells and heat-shock protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Molecular action of methotrexate in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Rheumatoid arthritis. Pathophysiology and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Therapeutic approaches to bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Bone loss in inflammatory arthritis: mechanisms and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Leflunomide in rheumatoid arthritis: recommendations through a process of consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

Problems encountered during anti-tumour necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1601

10.1517/13543784.16.10.1601

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference